Login / Signup

Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE.

Haotian ZhouXiaozhen ZhaoRuijun ZhangMiao MiaoWenwen PeiZijun LiYimin LiJing HeZhan-Guo LiXiaolin Sun
Published in: Signal transduction and targeted therapy (2023)
Keyphrases
  • low dose
  • systemic lupus erythematosus
  • high glucose
  • diabetic rats
  • high dose
  • disease activity
  • drug induced
  • rheumatoid arthritis
  • radiation therapy
  • endothelial cells